Complement factor 3 deficiency attenuates hemorrhagic shock-related hepatic injury and systemic inflammatory response syndrome

Am J Physiol Regul Integr Comp Physiol. 2010 Nov;299(5):R1175-82. doi: 10.1152/ajpregu.00282.2010. Epub 2010 Aug 11.

Abstract

Although complement activation is known to occur in the setting of severe hemorrhagic shock and tissue trauma (HS/T), the extent to which complement drives the initial inflammatory response and end-organ damage is uncertain. In this study, complement factor 3-deficient (C3(-/-)) mice and wild-type control mice were subjected to 1.5-h hemorrhagic shock, bilateral femur fracture, and soft tissue injury, followed by 4.5-h resuscitation (HS/T). C57BL/6 mice were also given 15 U of cobra venom factor (CVF) or phosphate-buffered saline injected intraperitoneally, followed by HS/T 24 h later. The results showed that HS/T resulted in C3 consumption in wild-type mice and C3 deposition in injured livers. C3(-/-) mice had significantly lower serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) and circulating DNA levels, together with much lower circulating interleukin (IL)-6, IL-10, and high-mobility group box 1 (HMGB1) levels. Temporary C3 depletion by CVF preconditioning also led to reduced transaminases and a blunted cytokine release. C3(-/-) mice displayed well-preserved hepatic structure. C3(-/-) mice subjected to HS/T had higher levels of heme oxygenase-1, which has been associated with tissue protection in HS models. Our data indicate that complement activation contributes to inflammatory pathways and liver damage in HS/T. This suggests that targeting complement activation in the setting of severe injury could be useful.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Alanine Transaminase / blood
  • Animals
  • Aspartate Aminotransferases / blood
  • Biomarkers / blood
  • Complement Activation*
  • Complement C3 / deficiency*
  • Complement C3 / genetics
  • DNA, Single-Stranded / blood
  • Disease Models, Animal
  • Elapid Venoms / administration & dosage
  • Femoral Fractures / complications
  • Femoral Fractures / immunology
  • HMGB1 Protein / blood
  • Heme Oxygenase (Decyclizing) / blood
  • Injections, Intraperitoneal
  • Interleukin-10 / blood
  • Interleukin-6 / blood
  • Liver / immunology*
  • Liver / metabolism
  • Liver Diseases / blood
  • Liver Diseases / genetics
  • Liver Diseases / immunology
  • Liver Diseases / prevention & control*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Shock, Hemorrhagic / blood
  • Shock, Hemorrhagic / genetics
  • Shock, Hemorrhagic / immunology*
  • Soft Tissue Injuries / complications
  • Soft Tissue Injuries / immunology
  • Systemic Inflammatory Response Syndrome / blood
  • Systemic Inflammatory Response Syndrome / genetics
  • Systemic Inflammatory Response Syndrome / immunology
  • Systemic Inflammatory Response Syndrome / prevention & control*
  • Time Factors

Substances

  • Biomarkers
  • Complement C3
  • DNA, Single-Stranded
  • Elapid Venoms
  • HMGB1 Protein
  • Hbp1 protein, rat
  • Interleukin-6
  • cobra venom factor
  • Interleukin-10
  • Heme Oxygenase (Decyclizing)
  • Hmox1 protein, rat
  • Aspartate Aminotransferases
  • Alanine Transaminase